Tag Archives: US healthcare reform

Healthcare reform and medical tourism

Will reforms to the US healthcare “system” impact medical tourism? Of course, no one can predict the future. Potential patients choose medical tourism for 5 reasons (http://www.imtjonline.com/articles/2008/medical-tourism-vs-traditional-international-medical-travel-a-tale-of-two-models/): cost, accessablity, availability, travel and confidentiality.

Perhaps the most likely thing to change as a result of reform efforts would be cost, although that is uncertain. Even if reform bends the curve, however, certain procedures will not be covered, like cosmetic surgery, and copays and deductables are likely to increase. The increase in patients seeking care for obesity , for example, drives patients to look for cheaper alternatives for care as well as other elective procedures. A sudden influx of over 30 million people into the system will tax the supply side of the equation and will take almost a generation to correct. Technologies, like stem cell treatments, are subject to political forces and regulatory pressure unlikely to change in the near future. Medical tourists, by definition, are not adverse to travel for care, sometimes combining it with a vacation or recuperation. Finally, there are people who just don’t want others at home to know they had “something done”.

Bottom line: As Niels Bohr noted, prediction is very difficult, especially about the future. The terms in this equation, however, reform outcomes seem to favor the growth of medical tourism.


Determinedly pro-academic-writers.com should be second to none place around.

Share Button

Outsourcing Bioscience Innovation

One of the unintended consequences of the health care reform proposals working their way through Congress could be US device and drug companies further outsourcing innovation to foreign shores. As recently pointed out by Dr. David Vequist, the Director of the Center for Medical Tourism Research at the Univeristy of the Incarnate World in San Antonio, Texas, there is a link between medical tourism and biotechnology (J Commercial Biotechnology,Oct 2009).

As countries like India, Turkey, Malaysis, Korea and Thailand place bigger and bigger bets on inbound medical tourism, their biotechnolgy and device sectors are coincidentally ramping up to provide new and unique techologies to visitors like stem cells, drugs and other treatments not available otherwise.

In addition, these countries are providing care without the regulatory and government regulations that drive up costs, something even a US Congressman, Jared Polis (R-CO), acknowledged when, it was recently reported, he made a subtantial investment in medical tourism.

Finally, pundits are suggesting that whatever the result of the US health care reform efforts, either higher costs, more regulation, decreased access or shrinking US bioscience innovation will continue to drive patients overseas for care.

Reform efforts, medical tourism and bioscience innovation are connected. The outcome might be the hub of device development shifting from Minneapolis to Mumbai.


At any time an individual www.essaynara.com through the google, learner become smarter!

Share Button

Domestic medical tourism: Old wine in a new bottle?

People are now calling referring patients to someone in the same country domestic medical tourism. Doctors call it an out-of-area referral. Whether the consulting physician is located in a place recognized for excellence in diagnosing or treating a particular illness, like National Jewish Hospital (Denver) for pulmonary care or MD Anderson Hospital (Houston) for cancer care, the usual model involves one provider referrring the patient to another provider. The referring provider takes responsiblity for sending the appropriate records and reassuming care for post treatment issues when the patient returns home.

Domestic medical tourism implies something different. First, patients armed with information provided by the Internet or medical tourism facilitators, are requesting care without necessarily seeking the referral or “permission” of their provider at home. Second, given improving price transparency, in part a response to the transparency of foreign providers, patients can shop for value, something their insurance providers are encouraging by covering some or all of the out of network charges. Finally, when patients return home, they may have trouble finding someone to care for them is they have had treatment, particularly sugery, somewhere else.

Domestic medical tourism will evolve as quality and outcomes data and prices become less opaque and as interstate insurance cooperatives or other insurance models make it easier for patients to go to the best place for care regardless of location.


Splendid article printing service guide precisely here that aches to benefit to as multiplied entities as desirable.

Share Button